why am i not losing weight with tirzepatide Can Help You Lose Weight? Why Am I Not Losing

launched an investigation into the potential self-harm and suicidal ideation risks that were being documented in patients taking Wegovy, Ozempic and other GLP-1 agonists

This can work against your efforts and make it harder to lose weight

In the SUSTAIN trials, semaglutide cut HbA1c by 1.5-1.9% at the 0.5-1.0 mg doses

Novo Nordisk said in a statement that the acquisition will increase the companys production capacity beginning in 2026

Due to their potential to improve mortality and morbidity outcomes, GLP-1 drugs are becoming an increasingly salient topic for insurers, particularly in relation to mortality improvement, medical underwriting, and new product development

While Mounjaro is a brand name for Tirzepatide, the medication itself works as a dual GLP-1 and GIP receptor agonist to regulate blood sugar and support weight loss